Journal of Nuclear Medicine Technology
2024年10月22日 · JNMT is the only peer-reviewed publication dedicated to nuclear medicine technology. Published quarterly, each issue features continuing education articles written by leading educators in nuclear medicine technology as well as news and updates on practice, licensure, and credentialing for nuclear medicine technologists.
About Us - Journal of Nuclear Medicine Technology
About the Journal of Nuclear Medicine Technology. Published by the technologist section of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), the Journal of Nuclear Medicine Technology (JNMT) focuses entirely on the technology crucial to nuclear medicine.In peer-reviewed articles, every quarter the journal offers recent technically centered articles on imaging and instrumentation ...
PET Imaging in Alzheimer Disease: Pathology and Research …
2 天之前 · Alzheimer disease (AD) is the sixth leading cause of death in the United States and is projected to affect over 13 million people by the year 2060. Although there is currently no cure for AD, disease-modifying treatments that target amyloid plaques have recently been approved for use. The advent of PET tracers that can reliably detect the presence of …
Delivery Methods of Radiopharmaceuticals: Exploring Global …
2 天之前 · In the world of nuclear medicine, health care professionals face the challenge of safeguarding themselves and their patients from occupational radiation exposure. As the field experiences exponential growth, driven by the surge in approvals of radiopharmaceuticals for diagnostic and therapeutic applications, it becomes vital to delve into the delivery methods of radiopharmaceuticals. Health ...
Amyloid Imaging Update: How the Amyloid Landscape Is …
2 天之前 · It has been some time since the Journal of Nuclear Medicine and Technology has published an article on best practices in amyloid imaging. In light of the recent Food and Drug Administration approval of new antiamyloid therapies (AATs) to decrease amyloid plaques in the brain and slow progression of mild cognitive impairment, and the potential increase in the number of amyloid PET scans being ...
SNM Practice Guideline for Lung Scintigraphy 4.0
2012年3月1日 · C. Radiopharmaceuticals. 99m Tc has a half-life of 6 h, a photopeak of 140 keV, and isomeric transition decay. 133 Xe has a half-life of 5.2 d, a photopeak of 81 keV, and β-decay. 81m Kr has a half-life of 13 s, a photopeak of 190 keV, and isomeric transition decay.. Aerosols. 99m Tc-diethylenetriaminepentaacetic acid (DTPA) is the most commonly used radiopharmaceutical.
Nuclear Medicine Clinical Practice in the United States During the ...
2020年9月1日 · Traditionally, practice in nuclear medicine has involved strong emphasis on radiation safety principles. Nuclear medicine technologists (NMTs) focus on practices that keep patients, the public, and the technologist safe from potentially harmful effects of unnecessary radiation exposure using concepts of time, distance, and shielding as well as ALARA (As low as reasonably achievable) principles ...
SNM Practice Guideline for Parathyroid Scintigraphy 4.0
2012年6月1日 · C. Radiopharmaceuticals. 99m Tc-sestamibi or 99m Tc-tetrofosmin. The range of intravenously administered radioactivity in adults is 740–1,110 MBq (20–30 mCi).This radiopharmaceutical localizes in both parathyroid tissue and thyroid tissue but usually washes out from normal and possibly abnormal thyroid tissue more rapidly than …
The Nuclear Medicine Technologist’s Role in Theranostics: SNMMI …
2022年9月1日 · With the approval of 177 Lu PSMA-617, theranostics’ presence in nuclear medicine is expanding beyond thyroid cancer and neuroendocrine tumors to higher-incidence diseases. This April (2022), The Journal of Nuclear Medicine published an ahead-of-print article, “Joint EANM, SNMMI and IAEA Enabling Guide: How to Set Up a Theranostics Centre” ().The guide provided valuable information to ...
JNMT Information for Authors - Journal of Nuclear Medicine …
Editorial Policy. Journal of Nuclear Medicine Technology (JNMT) publishes material of interest to practitioners and scientists in the fields of nuclear medicine and molecular imaging. Proffered articles describing original laboratory or clinical investigations, brief communications, and letters to the editor will be considered for publication.